Loading company details...
Latest Form 4 (Nov 12, 2026): Mark W. Sawicki (Chief Scientific Officer): Sale of 10,000 shares, $199.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Mark W. Sawicki, Chief Scientific Officer | Sale | 10,000 | $199.3K |
| Nov 12, 2026 | Daniel M. Hancock | Exercise/Conversion | 30,000 | $291.9K |
| Aug 11, 2026 | Jerrell Shelton, President, CEO | Sale | 28,800 | $429.4K |
| Jun 12, 2026 | Edward J. Zecchini, Chief Digital and Tech Officer | Exercise/Conversion | 1,400 | $6.7K |
| Jun 9, 2026 | Linda Baddour | Grant/Award | 10,350 | n/a |
| Jun 9, 2026 | Robert Stefanovich, Chief Financial Officer | Sale | 169,427 | $2.76M |
| Jun 9, 2026 | Daniel M. Hancock | Grant/Award | 10,350 | n/a |
| Jun 9, 2026 | Robert J. Hariri | Grant/Award | 10,350 | n/a |
| Jun 9, 2026 | Ramkumar Mandalam | Grant/Award | 10,350 | n/a |
| Apr 24, 2026 | Jerrell Shelton, President, CEO | Exercise/Conversion | 104,007 | $194.5K |